You are here: All Products  > Tanvex, a Taiwan Biotech, Approved to Market Neupogen Biosimilar in the US

Tanvex, a Taiwan Biotech, Approved to Market Neupogen Biosimilar in the US

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products